CompletedNCT02162953
Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases.
Studying Adult-onset foveomacular vitelliform dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Alan D. Marmorstein, Ph.D.Mayo Clinic
- Enrollment
- 48 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2014 – 2022
Study locations (1)
- Mayo Clinic, Rochester, Minnesota, United States
Collaborators
National Eye Institute (NEI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02162953 on ClinicalTrials.gov